Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice
Developmental Cell · 2023-11 · 58 (21) · 2326-2337.e5
DOI: 10.1016/j.devcel.2023.09.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Cell, 2023-11. Verfasst von Shuwei Hu und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Fudan University Shanghai, Shanghai 200032, China; Department of Integrative Medical Sciences, Northeast Ohio Medic…. Hauptthemen laut MEDLINE: Lipoproteins, HDL, Atherosclerosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Fudan University Shanghai, Shanghai 200032, China; Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
- Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
- Department of Pathology, School of Basic Medical Sciences, Fudan University Shanghai, Shanghai 200032, China.
- Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
- Department of Hepatobiliary Surgery, Peking University People's Hospital Xizhimen South Street, West District, Beijing 100044, China.
- Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
Zitieren
APA
Hu, S., Zhu, Y., Zhao, X., Li, R., Shao, G., Gong, D., Hu, C., Liu, H., Xu, K., Liu, C., Xu, M., Zhao, Z., Li, T., Hu, Z., Shao, M., Liu, J., Li, X., Wu, H., Li, J., & Xu, Y. (2023). Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice. Developmental Cell, 58(21), 2326-2337.e5. https://doi.org/10.1016/j.devcel.2023.09.007
Vancouver
Hu S, Zhu Y, Zhao X, Li R, Shao G, Gong D, et al. Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice. Developmental Cell. 2023;58(21):2326-2337.e5. doi:10.1016/j.devcel.2023.09.007
BibTeX
@article{Hu2023,
author = {Hu, Shuwei and Zhu, Yingdong and Zhao, Xiaojie and Li, Rui and Shao, Guangze and Gong, Dongxu and Hu, Chencheng and Liu, Hongjun and Xu, Kexin and Liu, Chenxi and Xu, Minghuan and Zhao, Zhonghua and Li, Tao and Hu, Zhigang and Shao, Mengle and Liu, Jun- and Li, Xinwei and Wu, Huijuan and Li, Jing and Xu, Yanyong},
title = {Hepatocytic lipocalin-2 controls HDL metabolism and atherosclerosis via Nedd4-1-SR-BI axis in mice},
journal = {Developmental Cell},
year = {2023},
volume = {58},
number = {21},
pages = {2326--2337.e5},
doi = {10.1016/j.devcel.2023.09.007}
}
EUVIMED